MORE THAN JUST REPRODUCTIVE HEALTH
The Women’s Health space is moving towards concentrating on the overall well-being of women throughout their entire life cycle, rather than their reproductive needs alone. Postmenopausal conditions, including vulvovaginal atrophy, that affect a woman’s quality of life are actively being researched for innovation of new therapies and dosage forms. With the rapid growth of this therapeutic area, the competition to enter into the market quickly is equally present. This quickness can be hindered by restrictive I/E criteria and by variable endpoints. Unpredictable factors like these can lead to unexpected complications when running Women’s Health trials.
Mouse over the image above for more information
Got a question? We’d love to hear from you
Send us a message and we’ll be happy to answer all your questions.
Navigating Complex Trials to Approvals
Biorasi’s methodology leverages our TALOS Ecosystem, an integrated technology and program management platform designed exclusively for Clinical Research. The efficiency of the TALOS Ecosystem offers greater success for our sponsors and allows faster trial completion while minimizing risk of failure.
Florida-Based CRO seeks to expand offerings, global footprint, and headcount after successful investment transaction. Biorasi, a leading full-service global contract research organization (CRO), is
Treating Women’s Health Holistically
Biorasi’s history in successfully running women’s health trials covers the full spectrum of women’s lives. This experience allows Biorasi to identify and proactively mitigate any anticipated challenges, and include one of the many board certified OBGYNs in our site network for successful study completion. Biorasi is capable and ready to provide your next women’s health study with the time, attention, and tailored solutions it deserves.